RBC Capital Says This Dystrophy Stock 'Is Worth A Look'

  • RBC Capital says Edgewise Therapeutics Inc's EWTX interim results from the ARCH study of EDG-5506 in Becker Muscular Dystrophy (BMD) improve reward/risk into October functional readout at 15 mg, which can help further de-risk the asset into the phase 2 BMD and Duchenne muscular dystrophy (DMD) studies.
  • The analysts believe stable patient NSAAs in October readout can potentially drive shares up 100% and further improve the setup into 2Q23 placebo-controlled randomized DMD readout and 2H23 placebo-controlled randomized BMD readout.
  • Safety continued to look clean with good tolerability, which we believe underscores a wide therapeutic window that can enable dosing of both BMD adults and adolescents, as well as DMD patients. 
  • Overall, the analyst continues to like the company given the encouraging clinical and preclinical data, experienced management team, and sufficient cash to reach major catalysts.
  • RBC believes Edgewise is worth a look, especially with DMD getting more spotlight.
  • Price Action: EWTX shares are up 5.95% at $7.84 during the market session on the last check Wednesday.

Posted In: BriefsAnalyst ColorBiotechNewsHealth CareSmall CapAnalyst RatingsMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.